GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » Total Long-Term Liabilities

Vectorite Biomedical (ROCO:4170) Total Long-Term Liabilities : NT$8.37 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Vectorite Biomedical's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was NT$8.37 Mil.

Vectorite Biomedical Total Long-Term Liabilities Historical Data

The historical data trend for Vectorite Biomedical's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectorite Biomedical Total Long-Term Liabilities Chart

Vectorite Biomedical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.65 9.10 8.94 8.53 8.37

Vectorite Biomedical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.94 8.80 8.53 8.63 8.37

Vectorite Biomedical Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Vectorite Biomedical Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectorite Biomedical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » Total Long-Term Liabilities
Comparable Companies
ROCO:6876 ROCO:6827 ROCO:6549 ROCO:7607 ROCO:6917 ROCO:4197 ROCO:6999 ROCO:6744 ROCO:6652 ROCO:6848 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Number 97, Section 1, Xintai 5th Road, 6th Floor, Floor-11, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Website
https://www.vectorite.com.tw
Vectorite Biomedical Inc is a Taiwan-based biotechnology research and development, cell product (preparation) manufacturing and immune cell collection and storage business.

Vectorite Biomedical Headlines

No Headlines